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Abstract
Introduction: Centralization has, among other aspects, been argued to have an im-
pact on quality of care in terms of surgical morbidity. Next, monitoring quality of care 
is essential in identifying areas of improvement. This nationwide cohort study was 
conducted to determine the rate of short-term surgical complications and to evaluate 
its possible predictors in women with early-stage cervical cancer.
Material and methods: Women diagnosed with early-stage cervical cancer, 2009 
FIGO stages IB1 and IIA1, between 2015 and 2017 who underwent radical hyster-
ectomy with pelvic lymphadenectomy in 1 of the 9 specialized medical centers in the 
Netherlands, were identified from the Netherlands Cancer Registry. Women were 
excluded if primary treatment consisted of hysterectomy without parametrial dis-
section or radical trachelectomy. Women in whom radical hysterectomy was aborted 
during the procedure, were also excluded. Occurrence of intraoperative and post-
operative complications and type of complications, developing within 30 days after 
surgery, were prospectively registered. Multivariable logistic regression analysis was 
used to identify predictors of surgical complications.
Results: A total of 472 women were selected, of whom 166 (35%) developed sur-
gical complications within 30 days after radical hysterectomy. The most frequent 
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1  | INTRODUC TION
For early-stage cervical cancer with a clinically visible lesion of ≤4 cm in 
greatest dimension, corresponding to 2009 International Federation of 
Gynecology and Obstetrics (FIGO) stages IB1 and IIA1, radical hyster-
ectomy with pelvic lymphadenectomy is the standard treatment.
Radical hysterectomy has proven to be highly effective in the 
treatment of early-stage cervical cancer with excellent survival 
rates. However, it is associated with surgical complications such as 
excessive blood loss, bladder dysfunction, abdominal organ inju-
ries, and wound infections.1 With the introduction of minimally in-
vasive techniques as an alternative to open radical hysterectomy, 
such as conventional laparoscopic surgery in the early 1990s and 
robot surgery in the following decade, the prevalence of complica-
tions has changed. Benefits of minimally invasive surgery include 
decreased blood loss, shorter length of hospital stay and fewer 
postoperative complications,2-5 but recently reported trial results 
show laparoscopic surgery to have a negative effect on recurrence 
and survival.6
In the Netherlands, radical hysterectomy for cervical cancer 
has been centralized to specialized medical centers since the late 
1990s, with a minimum of 20 procedures per year since 2012. This 
presumes high quality of care and a positive impact on the occur-
rence of short-term surgical complications. To be able to identify 
areas of improvement, monitoring short-term morbidity is essential.7 
Furthermore, few studies have reported multivariable models on risk 
factors for short-term intraoperative and postoperative complica-
tions.8 Therefore, the aim of this study was 2-fold: to determine the 
rate of short-term surgical complications in a nation with centralized 
surgical treatment for early-stage cervical cancer and to evaluate its 
possible predictors.
2  | MATERIAL AND METHODS
We performed a historical cohort study by analyzing data from the 
Netherlands Cancer Registry, a population-based registry with cov-
erage of all newly diagnosed malignancies in the Netherlands since 
1989. The Netherlands Comprehensive Cancer Organization is an in-
dependent institute that registers the data from >95% of the Dutch 
medical centers. The registration clerks routinely extract patient 
and complication information from medical records within hospitals. 
They all undergo the same extensive training, using 1 coding manual 
specifically developed for cervical cancer, creating uniformity in data 
interpretation and entry.
All women diagnosed with cervical cancer 2009 FIGO stage 
IB1 and IIA1 between January 2015 and December 2017 who 
underwent a radical hysterectomy by a gynecological oncologist, 
were included. Data on patient, treatment, tumor characteristics, 
and recurrence were collected. Women were excluded if primary 
treatment consisted of simple abdominal or vaginal hysterec-
tomy (ie, without parametrial dissection) or radical trachelectomy. 
Women in whom radical hysterectomy had been aborted during 
the procedure, for example, because of nodal involvement, were 
complications were urinary retention with catheterization in 73 women (15%) and 
excessive perioperative blood loss >1000 mL in 50 women (11%). Open surgery (odds 
ratio [OR] 3.42; 95% CI 1.73-6.76), chronic pulmonary disease (OR 3.14; 95% CI 1.45-
6.79), vascular disease (OR 1.90; 95% CI 1.07-3.38), and medical center (OR 2.83; 95% 
CI 1.18-6.77) emerged as independent predictors of the occurrence of complications. 
Body mass index (OR 0.94; 95% CI 0.89-1.00) was found as a negative predictor of 
urinary retention. Open surgery (OR 36.65; 95% CI 7.10-189.12) and body mass index 
(OR 1.15; 95% CI 1.08-1.22) were found to be independent predictors of excessive 
perioperative blood loss.
Conclusions: Short-term surgical complications developed in 35% of the women after 
radical hysterectomy for early-stage cervical cancer in the Netherlands, a nation with 
centralized surgical care. Comorbidities predict surgical complications, and open sur-
gery is associated with excessive perioperative blood loss.
K E Y W O R D S
hemorrhage, hysterectomy, intraoperative complications, postoperative complications, urinary 
retention, uterine cervical neoplasms
Key message
Short-term surgical complications developed in over one-
third of the women after radical hysterectomy. Chronic 
pulmonary disease and vascular disease are its independ-
ent predictors. Monitoring quality of care is advised in 
medical centers with limited experience in open surgery.
     |  3WENZEL Et aL.
also excluded. In the Netherlands, gynecologic oncologists from 
9 specialized medical centers are authorized to perform a radi-
cal hysterectomy for cervical cancer. To guarantee anonymity of 
center-specific data, medical centers were randomly categorized 
1 to 9. Vital status was obtained from the municipal demography 
registries. Data on recurrence and vital status were available until 
January 2019.
The set of surgical complications was registered according to 
national agreements in 2013 by the Working group on Oncological 
Gynecology of the Dutch Society of Gynecology and Obstetrics. 
Intraoperative and postoperative surgical adverse events occur-
ring within 30 days after surgery are prospectively registered. 
Complications were categorized as (a) being present or absent and 
(b) type of complications, including blood loss, functional disor-
der, infection, injury, systemic, technical, thrombosis, and wound 
defect.
The following possible predictors of the occurrence of complica-
tions were selected based on literature and availability of data: age 
at diagnosis, body mass index (continuous), type and number (0, 1, 
>1) of comorbidities, previous abdominal surgery, medical center, 
American Society of Anesthesiology classification, operative time, 
surgical approach (open, conventional laparoscopic, or robot surgery), 
simultaneously performed bilateral salpingo-oophorectomy, number 
of removed lymph nodes and positive lymph nodes, timing of radical 
hysterectomy, clinical tumor and pathological size, histological sub-
type, differentiation grade, and pathological parametrial invasion.
In literature, delaying radical hysterectomy until 6 weeks after 
a diagnostic excision was reported to result in fewer surgical com-
plications, impacted by parametrial inflammation.9 Accordingly, 
we categorized women who underwent radical hysterectomy 
after a diagnostic excision (eg, conization or large loop excision 
of the transformation zone) by timing: those receiving early radi-
cal hysterectomy (≤6 weeks) versus delayed radical hysterectomy 
(>6 weeks).
In the Netherlands Cancer Registry tumors are not classified ac-
cording to the FIGO staging system. Therefore, TNM stages (UICC 
TNM Classification of Malignant Tumors, 7th edn) were converted into 
FIGO stages, with clinical TNM stages T1b1, NX/0/1, M0, and T2a1, 
NX/0/1, M0 corresponding to FIGO stages IB1 and IIA1, respectively.
2.1 | Statistical analyses
Descriptive statistics were used to describe the characteristics and 
occurrence of surgical complications. Qualitative variables were ex-
pressed as absolute frequencies and percentages. For quantitative 
variables means and standard deviations were reported. Associations 
between complications and qualitative variables were assessed using 
Pearson's chi-squared test. Quantitative variables were assessed by 
independent samples t-test. To identify risk factors associated with 
the occurrence of complications, backward logistic regression analy-
ses were performed. Candidate predictors from univariable analyses 
were included in the multivariable model if P < .10 or if associated 
with complications, according to literature (ie, delayed radical hyster-
ectomy). Comorbidities were grouped in categories (see Table 2) and 
included as binary variables (absent/present) in the logistic regression 
analyses. Converted patients remained in the laparoscopic surgery 
group for analysis, according to the intention-to-treat principle. The 
medical center with the median number of women with complications 
was set as reference category. Kaplan-Meier analysis was used to es-
timate disease-free and overall survival rates. All analyses were per-
formed using Stata/SE version 14.2 (Stata Corp., College Station, TX, 
USA). Statistical tests were 2-tailed and independent predictors were 
considered significant at P < .05.
2.2 | Ethical approval
This study was approved by the Privacy Review Board of the 
Netherlands Cancer Registry (03/12/2018; K18.375).
3  | RESULTS
Of the 2309 women with cervical cancer diagnosed in the Netherlands 
between 2015 and 2017, 472 were selected for this study (see 
F I G U R E  1   Patient selection flowchart
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Figure 1). Patient, tumor, and treatment characteristics are summarized 
in Table 1. Mean age of the women was 45 ± 12 years and mean body 
mass index was 26 ± 5 kg/m2. Vascular disease (14%) was the most 
prevalent comorbidity (see Table 2). Sixty-three women (13%) had mul-
tiple comorbidities. The predominant FIGO stage was IB1 (97%) and 
women were mainly treated with open surgery (58%). Conversion rate 
from laparoscopic to open surgery was 1% (n = 2). In 1 woman no pelvic 
lymphadenectomy was executed, for undocumented reasons.
Recurrence and vital status information was available for 449 
women (94%). Median follow-up duration for disease-free survival 
and overall survival were 22 months and 30 months, respectively. 
Thirty-seven of the women (8%) had developed a recurrence and 
17 (4%) had died at the time of analysis. Disease-free survival and 
overall survival were 87% and 95%, respectively.
Surgical complications within 30 days after radical hysterec-
tomy were reported in 166 women (35%). In 2015, 73% of the 
patients were treated by open surgery and 37% experienced a 
complicated course, whereas in 2017 these values were 43% 
(P < .001) and 33% (P = .745), respectively. For definitions of types 
TA B L E  1   Characteristics of 472 women with cervical cancer 
(FIGO stage IB1 and IIA1) treated with radical hysterectomy 
between 2015 and 2017 in the Netherlands, related to the 
occurrence of complications
Patient characteristics  Pb
Age, years (SD) 45 (12) .084
Body mass index, kg/m2 (SD) 26 (5) .021
Previous abdominal surgery, n (%)
Absent 310 (66) .891
Present 155 (33)
Unknown 7 (1)
ASA classification, n (%)





Operative time, min (SD) 260 (89) .387
Surgical approach, n (%)
Open 271 (57) .002
Conventional laparoscopic 70 (15)
Robot 131 (28)
Bilateral salpingo-oophorectomy, n (%)




Removed, mean (SD) 25 (10) .220
Positive, n (%) 71 (16) .419
Timing radical hysterectomya, n (%)
Early (≤6 weeks) 109 (23) .114
Delayed (>6 weeks) 178 (38)
No diagnostic excision 186 (39)
Tumor characteristics
Clinical tumor size, n (%)
<20 mm 170 (36) .469
≥20 mm 224 (47)
Unknown 79 (17)
Histological subtype, n (%)
Squamous cell carcinoma 302 (64) .306
Adenocarcinoma 141 (30)
Adenosquamous carcinoma 19 (4)
Other 10 (2)
Differentiation grade, n (%)





Patient characteristics  Pb
Pathological parametrial invasion, n (%)
Absent 407 (86) .888
Present 22 (5)
Unknown 43 (9)
Pathological tumor size, mm (SD) 23 (13) .988
Abbreviation: ASA, American Society of Anesthesiology.
aAfter diagnostic conization/large loop excision of the transformation 
zone. 
bt-test for continuous variables, χ2-test for categorical variables in 
univariable analysis; because of rounding, percentages might not sum 
to 100%. 
TA B L E  1   (Continued)
TA B L E  2   Number of comorbidities organized by category, 
related to the occurrence of complications
Comorbidity category n (%) Pa
Prior malignancy 15 (3) .880
Cardiac disease 20 (4) .987
Vascular disease 65 (14) .011
Diabetes mellitus 15 (3) .134
Chronic pulmonary disease 34 (7) .001
Neurological/psychiatric disease 30 (6) .079
Gastrointestinal and liver disease 39 (8) .193
Urogenital disease 6 (1) .444
Thrombosis 9 (2) .196
Muscle, connective tissue and joint disease 8 (2) .103
Endocrine 18 (4) .401
Infectious disease 2 (0) .660
aχ2-test for univariable analysis. 
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of complications, see Table 3. The main complication was urinary 
retention with catheterization (ie, catheter at discharge, reinser-
tion, or prolonged hospital stay) in 73 women (15%), followed by 
excessive perioperative blood loss >1000 mL in 50 women (11%). 
Of all women with complications, 49 (30%) developed multiple 
complications. The median percentage of women with surgical 
complications per medical center was 30%.
Results from logistic regression analysis on the occurrence of 
surgical complications, are reported in Table 4. In univariable anal-
ysis, age (P = .085), body mass index (P = .022), >1 comorbidities 
(P = .004), chronic pulmonary disease (P = .001), neurological/psy-
chiatric disease (P = .083), vascular disease (P = .012), and surgical 
approach (P = .001) were associated with the occurrence of com-
plications. Timing of radical hysterectomy (early vs delayed) was 
not significantly related to the occurrence of complications (38% vs 
29%, respectively) (P = .115). Finally, in medical center 9 significantly 
more surgical complications were registered than the median per-
centage (63% vs 30%, P = .001).
Variables associated with surgical complications were entered 
into a multivariable logistic regression analysis model. Open sur-
gery compared with robot surgery (odds ratio [OR] 3.42; 95% CI 
1.73-6.76; P < .001), chronic pulmonary disease (OR 3.14; 95% 
CI 1.45-6.79; P = .004), vascular disease (OR 1.90; 95% CI 1.07-
3.38; P = .028), and medical center 9 (OR 2.83; 95% CI 1.18-
6.77; P = .019) emerged as independent predictors of surgical 
complications.
Similar analyses were executed for the most prevalent compli-
cations urinary retention with catheterization and excessive periop-
erative blood loss. We found body mass index to be an independent 
predictor for urinary retention (OR 0.94; 95% CI 0.89-1.00; P = .043). 
For analysis purposes (blood loss >1000 mL did not occur in women 
who underwent robot surgery), conventional laparoscopic and robot 
surgery were combined and compared with open surgery, in exam-
ining excessive blood loss. Open surgery (OR 36.65; 95% CI 7.10-
189.12]; P < .001) and body mass index (OR 1.15; 95% CI 1.08-1.22; 
P < .001) were found to be independent predictors of excessive 
perioperative blood loss.
4  | DISCUSSION
This study shows that intraoperative and postoperative short-term 
surgical complications occurred in over one-third of the women 
after radical hysterectomy for early-stage cervical cancer. This in-
dicates that, in terms of morbidity due to surgery, despite centrali-
zation of a relatively infrequent operation, there is still room for 
improvement of quality of care. Looking into possible predictors 
for the development of surgical complications, we identified sur-
gical approach, chronic pulmonary disease, vascular disease, and 
medical center as independent predictors of the development of 
surgical complications.
It has been argued that centralization of surgical care for cervi-
cal cancer results in fewer surgical complications.7 Centralization 
provides medical centers with more cases to treat, consequently 
increasing surgical experience and outcome. For example, a study 
by Trimbos et al reported that blood loss decreased from 1515 mL 
to 1071 mL and operating time decreased by nearly 90 minutes in 
open radical hysterectomy over a 13-year period.10 The study was 
executed in 1 single institution with the same surgical team and a 
similar 5-year survival rate to other gynecological cancer centers 
around the world. The authors conclude that it takes a strikingly 
long time to achieve surgical experience. In the present study, we 
found that, in a nation with centralized radical hysterectomy pro-
cedures, surgical complications within 30 days after surgery de-
veloped in over one-third of the women. In comparison, recently 
published results from the “Laparoscopic Approach to Cervical 
Cancer” trial showed 11% of the women to have intraoperative 
complications and 25% to have early postoperative complications 
within 6 weeks after surgery.6
As mentioned earlier, radical hysterectomy for cervical cancer is 
centralized to 9 specialized medical centers in the Netherlands. Two 
of these centers only perform open surgery, whereas some gyne-
cological oncologists from other centers are mainly trained in min-
imally invasive procedures. The trial by Ramirez et al reopened the 
TA B L E  3   Short-term surgical complications, organized by 
category
Surgical complications n (%)
Hemorrhage
Perioperative >1000 mL 50 (11)
Postoperative 14 (3)
Functional disorder














Corpus alienum 1 (0)
Thrombosis
Deep vein thrombosis 2 (0)
Pulmonary embolism 2 (0)
Wound defect
Wound dehiscence 7 (1)
Platzbauch 1 (0)
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debate on surgical approach in early-stage cervical cancer, arguing 
that open radical hysterectomy is superior over laparoscopy regard-
ing recurrence rates and disease-free survival.6 In the aftermath of 
this trial, a shift can be expected towards open surgery. However, 
advocating open surgery as treatment of choice poses challenges to 
countries where surgery for cervical cancer is organized similarly to 
the Netherlands. For those with limited experience in open surgery, 
altering surgical approach means facing a new learning curve. Such 
changes possibly affect the quality of surgical care, making it essen-
tial to monitor outcome parameters.
We identified surgical approach as an independent predictor for 
surgical complications. Open surgery as predictive factor of overall 
complications was primarily accounted for by excessive periopera-
tive blood loss, with 98% of the cases registered in those treated 
with open surgery (P < .001). As stated previously, this is in accor-
dance with multiple reviews on radical hysterectomy, which report 
higher blood loss in women who undergo open surgery versus 
conventional laparoscopic or robot surgery.3,11 However, in the stud-
ies under review, blood loss was measured as average number of 
millilitres, whereas in our study excessive blood loss is defined using 
a cutoff of 1000 mL. In a review by Zhao et al,11 mean blood loss was 
approximately 180 mL higher in women treated by open surgery. In 
open surgery studies, means ranged from 145 to 836 mL, whereas 
mean blood loss in laparoscopic surgery ranged from 65 to 449 mL. 
This offers a possible explanation for the near absence of excessive 
blood loss in our laparoscopic surgery sample.
Next, body mass index emerged as independent predictor of exces-
sive perioperative blood loss (P < .001). The relation between obesity 
and surgical complications has been reported previously. Specifically, 
blood loss has been associated with obesity in several studies on radi-
cal hysterectomy for cervical cancer.12-15 In part, this may be attributed 
to surgery in obese women being technically more difficult.
Chronic pulmonary disease and vascular disease also emerged 
as predictors of complications (P = .004 and P = .028, respectively). 











OR 95% CI P
Age, years (SD) 47 (12) 45 (11) .085    
Body mass index, kg/m2 (SD) 26 (5) 25 (5) .022
Number of comorbidities, n (%)
0 94 (57) 205 (67) Reference    
1 40 (24) 70 (23) .347
>1 32 (19) 31 (10) .004
Type of comorbidities, n (%)
Chronic pulmonary disease 21 (13) 13 (4) .01 3.14 1.45-6.79 .004
Neurological/psychiatric disease 15 (9) 15 (5) .083    
Vascular disease 32 (19) 33 (11) .012 1.90 1.07-3.38 .028
Medical center, n (%)
1 14 (8) 27 (9) .701    
2 13 (8) 30 (10) Reference
3 8 (5) 29 (9) .385
4 25 (15) 43 (14) .480
5 11 (7) 30 (10) .730
6 9 (5) 27 (9) .606
7 23 (14) 51 (17) .924
8 17 (10) 42 (14) .877
9 46 (28) 27 (9) .001 2.83 1.18-6.77 .019
Surgical approach, n (%)
Robot 31 (19) 100 (33) Reference    
Laparoscopic 23 (14) 47 (15) .163
Open 112 (67) 159 (52) .001 3.42 1.73-6.76 <.001
Timing radical hysterectomy, n (%)
Early 41 (25) 68 (22) Reference    
Delayed 51 (31) 127 (42) .115
aNonsignificant results omitted for clarity; OR, odds ratio; CI, confidence interval; because of rounding, percentages might not sum to 100%. 
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Comorbidities have long been linked to the development of surgical 
complications. Moreover, chronic pulmonary disease and vascular 
disease have been reported as predictors of perioperative and post-
operative complications in gynecological cancer.16-22
Timing of radical hysterectomy after a previous diagnostic pro-
cedure was reported to be a predictor of developing complications.9 
Receiving early (ie ≤6 weeks after diagnostic excision) radical hys-
terectomy was associated with more complications, because of a 
hypothesized impact of parametrial inflammation, than receiving 
delayed radical hysterectomy. With our data, comparing surgical 
approach, no significant associations were found between timing of 
radical hysterectomy and complications. Therefore, we cannot con-
clude that timing of radical hysterectomy is a predictor of short-term 
surgical complications. An explanation for the discrepancy may lie in 
the different types of complications that were investigated in both 
studies.
The strength of our study is that by using data from the 
Netherlands Cancer Registry, a nationally representative sample 
of the Dutch population was investigated. It provides data from re-
al-world clinical practice instead of a controlled trial environment. 
By integrating data from multiple gynecological centers, it avoids 
the weakness of single center studies. Furthermore, monitoring 
quality of surgical care by an independent institute increases the 
ability to identify areas of improvement,7 avoiding possible un-
derrepresentation on the outcome of interest. In the Netherlands 
Cancer Registry, gynecological data are registered shortly after 
primary treatment is completed to be able to provide physicians 
with up-to-date feedback. This registration of short-term data in-
evitably results in the absence of long-term complications in our 
database. Consequently, the focus of this study was only on short-
term complications.
A limitation of observational research is that it depends on the 
quality of data in the medical record. For example, if 1 hospital is 
less accurate in the registration of complications, this underrep-
resentation might result in a misclassification bias. In the present 
study, 1 hospital used their own registration clerks, which might 
have induced bias. However, excluding their data from the analysis 
did not alter the results. One major limitation is the absence of 
information on severity in the registration of complications. In sur-
gically treated gynecological tumors, situations deviating from the 
normal are registered as surgical complications, although they are 
not graded as in, for example, the Clavien-Dindo classification.23 
For example, the bladder catheter placed during surgery is not 
classified as a complication. Whereas, in the case of catheter rein-
sertion, hospital discharge with catheter and readmission because 
of urinary retention it is classified as a complication. Another lim-
itation is the registration of comorbidities. Although comorbidities 
are registered in the Netherlands Cancer Registry, their severity 
is not. Selection may have affected our results as women with se-
vere comorbid disease have possibly been excluded from surgery 
and assigned to primary radiotherapy, instead. Vascular disease 
(14%) and chronic pulmonary disease (7%) are relatively common 
in our cohort. However, this is probably caused by the inclusion of 
hypertension in the definition of vascular disease and asthma in 
the definition of chronic pulmonary disease. Furthermore, in our 
study no differentiation was made in the extent of radicality and 
nerve sparing. As morbidity of the radical hysterectomy is propor-
tional to the extent of resection, its influence on the development 
of complications could not be examined. Finally, in medical cen-
ters performing both open and laparoscopic procedures, high-risk 
patients might have been selected for open surgery more often. 
Although our analysis adjusted for age, body mass index,, and co-
morbidities, there might have been other predictors that we have 
not corrected for.
5  | CONCLUSION
Short-term surgical complications develop in 35% of women 
after radical hysterectomy for early-stage cervical cancer in the 
Netherlands, a nation with centralized surgical care. We found open 
surgery to be associated with more frequent excessive perioperative 
blood loss, whereas chronic pulmonary disease and vascular disease 
are independent predictors of the occurrence of surgical complica-
tions in general. Accordingly, we suggest that women are informed 
during the treatment decision-making process about the possible 
consequences of surgical approach and comorbidities.
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